Menu Menu


GSK Financials       Clear


GSK        0001131399    
Filing Date Form Type Description Document
2021-02-16 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-12 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2021-02-12 SC 13G/A AMENDMENT TO FORM SC 13G View Document
2021-02-12 SC 13G/A AMENDMENT TO FORM SC 13G View Document
2021-02-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-11 3 OWNERSHIP DOCUMENT View Document
2021-02-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-04 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-03 6-K FINAL RESULTS View Document
2021-02-03 6-K GSK/CUREVAC PARTNER ON NEW MRNA COVID-19 VACCINES View Document
2021-02-01 6-K TOTAL VOTING RIGHTS View Document
2021-01-29 SC 13G/A View Document
2021-01-26 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-22 6-K FDA APPROVES VIIV HEALTHCARE'S CABENUVA FOR HIV View Document
2021-01-20 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-20 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-20 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-04 6-K TOTAL VOTING RIGHTS View Document
2020-12-30 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-12-23 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-12-21 6-K VIIV FIRST LONG-ACTING HIV REGIMEN APPROVED IN EU View Document
2020-12-11 6-K SANOFI/ GSK UPDATE ON COVID VACCINE CANDIDATE View Document
2020-12-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-12-10 6-K BLOCK LISTING APPLICATION View Document
2020-12-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-12-07 SC 13D/A AMENDMENT NO. 5 TO SC 13D View Document
2020-12-07 SC 13D/A AMENDMENT NO. 2 TO SC 13D View Document
2020-12-03 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-12-01 6-K TOTAL VOTING RIGHTS View Document
2020-11-30 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP View Document
2020-11-27 6-K GSK PUBLISHES PROVISIONAL 2021 DIVIDEND DATES View Document
2020-11-27 6-K EMTN SUPPLEMENTARY PROSPECTUS View Document
2020-11-25 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-23 6-K BLOCK LISTING INTERIM REVIEW View Document
2020-11-19 6-K HOLDING(S) IN COMPANY View Document
2020-11-17 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-12 6-K MEDICAGO GSK PHASE 2/3 STUDY START View Document
2020-11-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-09 6-K VIIV'S CABOTEGRAVIR SUPERIOR FOR HIV PREVENTION View Document
2020-11-06 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-11-04 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-04 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-03 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-03 6-K GSK SETS NEW ENVIRONMENTAL GOALS View Document
2020-11-02 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-02 6-K TOTAL VOTING RIGHTS View Document
2020-10-30 6-K HOLDING(S) IN COMPANY View Document
2020-10-30 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-28 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-28 6-K 3RD QUARTER RESULTS View Document
2020-10-28 6-K SANOFI AND GSK SUPPORT COVAX - 200M VACCINE DOSES View Document
2020-10-22 6-K HOLDING(S) IN COMPANY View Document
2020-10-16 6-K POSITIVE CHMP OPINION VIIV LONG-ACTING HIV REGIMEN View Document
2020-10-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-13 25-NSE View Document
2020-10-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-07 CERT NYSE CERTIFICATION View Document
2020-10-01 8-A12B 8-A12B View Document
2020-10-01 6-K 6-K View Document
2020-10-01 6-K TOTAL VOTING RIGHTS View Document
2020-10-01 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-09-30 424B2 424B2 View Document
2020-09-28 FWP FWP View Document
2020-09-28 FWP FWP View Document
2020-09-28 424B2 424B2 View Document
2020-09-28 6-K 6-K View Document
2020-09-22 6-K SANOFI/GSK AGREE UP TO 72M CANADA COVID DOSES View Document
2020-09-18 4 OWNERSHIP DOCUMENT View Document
2020-09-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-09-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-09-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-09-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-09-03 6-K SANOFI/GSK: PHASE 1/2 TRIAL OF COVID-19 VACCINE View Document
2020-09-01 6-K TOTAL VOTING RIGHTS View Document
2020-08-24 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP View Document
2020-08-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-08-06 6-K US FDA APPROVES GSKS BLENREP FOR MULTIPLE MYELOMA View Document
2020-08-03 6-K TOTAL VOTING RIGHTS View Document
2020-08-03 6-K SANOFI/GSK TO SUPPLY EU WITH 300M COVID 19 DOSES View Document
2020-08-03 SC 13D ACQUISITION OF BENEFICIAL OWNERSHIP View Document
2020-07-31 6-K SANOFI & GSK PICKED FOR OP. WARP SPEED BY US GOV. View Document
2020-07-30 4 OWNERSHIP DOCUMENT View Document
2020-07-29 6-K 2ND QUARTER RESULTS View Document
2020-07-29 6-K DIRECTOR/PDMR SHAREHOLDING View Document

Find registration statements, periodic reports, and other forms by typing ticker symbol of a company.

Ticker:

Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.



We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas